Navigation Links
Manhattan Research: ePharma Consumer(R) Research and Advisory Service Now Available

Service Provides Users with Insight into Pharmaceutical Information Use and

Online Media Trends

NEW YORK, Jan. 28 /PRNewswire/ -- Manhattan Research, a leader in syndicated research and marketing services for the health and pharmaceutical industry, announced today that the strategic research and advisory service ePharma Consumer(R) is available for subscribing clients. This online study of U.S. consumers includes trended data for over five years coupled with insight from one of the world's leading authorities on healthcare and information technology adoption.

"ePharma Consumer provides our agency and pharmaceutical clients with insight into how consumers are using branded and unbranded pharma properties online today," states Meredith Abreu Ressi, VP Research for Manhattan Research. "Combining this research with server and usage data is critical to painting a complete strategic picture of the online consumer marketing and media landscape."

ePharma Consumer(R) explores topics such as online pharmaceutical information resources, DTC advertising, utilization and trust of online Rx information, pharmaceutical company and Rx product websites, search engine use, use of blogs, podcasts, wikis, social networking, and more. Global pharma companies and agencies alike rely on this advisory service year after year for budget planning, product site development, market sizing, and ROI measurement for online initiatives.

The ePharma Consumer(R) research and advisory service helps planners and marketers to:
-- Examine consumer use of pharmaceutical information online and trends

over time

-- The impact of Web 2.0 on consumer pharmaceutical marketing strategy

-- Utilization trends for 30+ corporate and 150+ branded product sites

-- Determine the profile of online visitors by brand (Rx status,

caregiver, or information seeker)

-- Assess the actions taken offline after visiting product sites vis-a-vis

competitor sites

-- Features and tools desired by consumers visiting product sites

Please visit to download the ePharma Consumer(R) product brochure, request subscription information, and to listen to two audio presentations summarizing highlights from the research.


ePharma Consumer(R) v7.0 is a syndicated multi-client study and advisory service focused on key research topics and trends impacting online U.S. consumers seeking pharmaceutical information. The study was fielded in December 2007 among 5,112 U.S. adult consumers.

In addition to ePharma Consumer(R), Manhattan Research conducts five additional research studies annually among consumers and physicians in the United States and in Europe: Cybercitizen(R) Health US, Cybercitizen(R) Health Europe, Taking the Pulse(R) US, Taking the Pulse(R) Europe, and ePharma Physician(R). Each study serves a unique purpose and focuses on specific aspects of information technology adoption. Broad consumer and physician research is complemented by targeted analyses among more than 50 consumer therapeutic segments and 25 physician specialist segments.

CONTACT: Erica Alexander

Manhattan Research


SOURCE Manhattan Research
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Stanford researchers find culprit in aging muscles that heal poorly
2. Children of depressed moms do better when dad is involved, SLU researcher finds
3. UCLA researchers identify markers that may predict diabetes in still-healthy people
4. Mayo Clinic researchers discover new diagnostic test for detecting infection in prosthetic joints
5. New research shows how chronic stress worsens neurodegenerative disease course
6. New research explores newborn in-hospital weight loss
7. Research may unlock mystery of autisms origin in the brain
8. Bipolar disorder relapses halved by Melbourne researchers
9. HIVs impact in Zimbabwe explored in new research
10. U.S. Research Funding Continues to Flatten as U.S. Health Costs Climb - in August 31 Science
11. Cell that triggers symptoms in allergy attacks can also limit damage, Stanford researchers find
Post Your Comments:
(Date:11/26/2015)... ... November 26, 2015 , ... ... wellness consultation, has collaborated with Women’s Web – an online resource for ... topics on mental and emotional well-being relationship, life balance, stress, professional development, ...
(Date:11/25/2015)... ... November 25, 2015 , ... The holiday season is ... pleasing the palates of attendees is of the utmost importance. Whether you are ... get-together, give these recipes a try this holiday season. , Turkey Croquettes , ...
(Date:11/25/2015)... Vegas, NV (PRWEB) , ... November 25, 2015 , ... ... invites patients to learn more about hair loss treatment with the Capillus272™ Pro laser ... an effective solution for thicker and fuller hair, without the need for surgery, prescription ...
(Date:11/25/2015)... ... 2015 , ... According to an article published November 10th by ... heralded as a breakthrough for performing hernia repairs. The article explains that the biggest ... that it can greatly reduce the pain that a patient might otherwise experience after ...
(Date:11/25/2015)... Florida (PRWEB) , ... November 25, 2015 , ... ... testing for physicians and athletic programs, launches new Wimbledon Athletics Facebook ... of testing young athletes for unsuspected cardiac abnormalities. About 2,000 people under the ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... November 25, 2015 Kitov Pharma ... (TASE: KTOV), a biopharmaceutical company focused on the development ... clinical conditions, today announced the closing of its previously ... ( ADSs ), each representing 20 ordinary shares of ... ADSs. The ADSs and warrants were issued in a ...
(Date:11/25/2015)... , Nov. 25, 2015  Trovagene, Inc. (NASDAQ: ... today announced that Chief Executive Officer Antonius Schuh, Ph.D., ... 27 th Annual Piper Jaffray Healthcare Conference. ... the New York Palace Hotel in New ... 1:30 p.m. EST. Mr. Schuh will be available for ...
(Date:11/25/2015)... , Nov. 25, 2015 Allergan ... pharmaceutical company, and Rugen Therapeutics, a start-up  biotechnology ... for unmet CNS disorders and funded by the ... they have entered into an exclusive collaboration to ... for Autism Spectrum Disorders (ASD) and Obsessive Compulsive ...
Breaking Medicine Technology: